The present study included 45 
INTRODUCTION
Interleukin 10 is considered as a typical cytokine released from activated T-helper type 2 cells. A complete-IL-10 molecule includes 160 amino-acids with molecular weight ranging from 35 to 70 KDA, and can suppress proliferation and cytokine secretion of T-helper type I cells such as IL-2, IFN-γ. It can, also, suppress immuno -reaction induced by T-helper -1-cells and induce Blymphocytes into presenting antigen that matches with the molecule of major histocompitability complex II (MHC II) to facilitate humoral immunity and neutralize extracellular pathogenesis (1) .
Recruitment of virus-specific Tlymphocyte subpopulation to liver sites: chronic HCV infection implies a key role for the immune response in host virus interaction. In spite of a multi-specific and polyclone cytotoxic function exerted by CD8+ lymphocytes, CD-mediated activity weak. This allows the infection to persist which is responsible for development of chronic hepatitis C (CH-C) such a finding outline the occurrence of a possible relationship between cytokine (CK) production by CD4 subsets, i.e. T helper (Th 1) or Th2 cells, and the clinical outcome (2) . A prevalence of Th 1 derived CK occurs in infected liver, while increased amounts of Th 2 related CK are usually found in peripheral blood. Peripheral blood mononuclear cells cultures from CH-C subjects exhibits an impaired IFN-γ production and favor IL-10 induced effects (2) . Type I and type II lymphocytes are not derived from different lineages but develop from the same precursors, and their differentiation is influenced by the environment during priming.
The most important signals are cytokines themselves: IL-12 produced by activated macrophages is the principle cytokine inducing type I responses, whereas the development of type 2 lymphocytes is induced by IL-4 and IL-10 (3) . The cytokine interleukin-10 (IL-10) has pleiotropic effects on a number of different cell types. In general it is regarded as a suppressor of immune responses because it inhibits the secretion of proinflammatory and antiviral cytokines such as TNF-α and interferon-γ (IFN-γ). IL-10 inhibits the development and activation of CD4+ T-helper lymphocytes with a Th1 (IFN-γ secreting) phenotype (4) . Interleukin-10-secreting antigenspecific regulatory cells may contribute to viral persistence, and demonstrate the peripheral blood mononuclear cells (PBMC), from chronically HCV-infected patients secrete IL-10, but not IFN-γ in response to HCV non-structural protein (NS4) (5) . A neutralizing anti-IL-10 antibody restored this defective antigen-specific IFN-γ production in vitro. PBMC from normal individuals secreted IL-10 in response to NS4 suggesting that cells of innate immune system in addition to T-cells produced IL-10 in the HCV infected patients (5) . On basis of the previous data the present work was designed to evaluate the role of Interleukin 10 as a marker of T-helper 2 activity and its importance in chronicity of hepatitis C virus.
SUBJECTS & METHODS
Forty five subjects were included in the study. They were divided into 3 groups: Group (I) (control group All data were expressed as mean ± SD for quantitative variables; number and percentage for qualitative ones (6) .
RESULTS
The results of the current study revealed that:  The comparison between liver function tests (ALT, AST, ALP, GGT, serum albumin, total protein, albumin/globulin ratio, prothrombin concentration and IL10) in the three studied groups are shown in 1) .  There was highly significant decrease of serum albumin in group II when compared to control group (P < 0.001). There was no statistically significant difference between group III and the control group (P > 0.05). The mean serum albumin of group III was statistically significantly higher than group II (P < 0.001).  There was highly significant decrease of total protein in groups II and III when compared with the control group (P < 0.001). There was no statistically significant difference between group II and group III (P > 0.05).  There was statistically significant increase of A/G in group III when compared with the control group (P = 0.01). There was no statistically significant difference between group II and control group (P > 0.05).  There was highly significant decrease of prothrombin concentration in groups II and III when compared with the control group (P < 0.001). There was a statistically significant increase in prothrombin concentration in group III when compared with group II (P < 0.001).  There was highly significant increase of IL-10 in groups II and III when compared with control group (P<0.001), also there was highly significant increase of IL-10 in group III when compared with group II (P<0.001) ( . On basis of the previous data the current work was designed to evaluate the role of IL-10 as a marker of Thelper 2 activity and its importance in chronicity of hepatitis C virus.
The present data were in agreement with those of Brady and his Colleagues (5) , who stated that HCV subverts cellular immunity by inducing IL -10 and inhibiting IL -12 production by monocytes, which in turn inhibits the activation of DC that drive the differentiation of Th 1 cells. Also, it was reported by Cacciarell and his colleagues, (9) and Hongyu and his colleagues (1) that IL-10 levels become elevated in patients with chronic hepatitis C.
The serum level of IL-10 was assayed in 10 normal subjects, 24 HCV carriers and 27 patients with chronic hepatitis C. The serum level of IL-10 was much higher in the patients with chronic hepatitis C than in normal controls and HCV carriers with a positive relation to the values of ALT (1) . The present findings are in line with a previous report by Kakumu and his colleagues (10) who reported increased IL-10 levels but unaltered IL -12 production in monocular cells of patients with chronic hepatitis C.
In addition, Abayli and his colleagues.
(11) concluded that serum levels of IL-4, IL-10 but not IFN-γ were found to be significantly increased in chronic HCV patients compared to those of control subjects. That finding may suggest the involvement of TH2 cytokines in the pathogenesis of chromic hepatitis C virus liver disease.
Also, the numbers of IL-10 producing monocytes were at least twofold higher in patients with chronic hepatitis C than in aviremic anti HCV seropositives and the controls thus in chronic hepatitis C antigen-specific cytokine induction in monocytes is apparently shifted towards predominant IL-10 induction (3) . Another study measured the levels of cytokines in the culture supernatant of PBMCs compared with the cytokine level of normal control, the levels of IFN-γ, TNF -α and IL-10 of HCV patients notably increased while IL-2, IL-4, and IL-12 were not detected in the culture supernatant of PBMCs from both normal control and HCV patients after culture for 72 hours (12) . Another study that is supported by the present results had revealed that the levels of IL-18, IL-10, TNFalpha and sIL-2 in the patients of chronic hepatitis C were higher than those in the healthy controls and in asymptomatic HCV carriers. IL-18, IL-10, TNF-α and sIL-2 coparticipate in the pathogenesis of chronic hepatitis C, and are used to evaluate the effect of IFN on the immune state of organisms, and IL -10 and sIL-2 are important for predicting the anti-viral efficacy of IFN (13) .
Controversial to the present results, the results of Hassoba and his colleagues.
(14) that was performed on 66 Egyptian patients of chronic Hepatitis -C related illness and showed that spontaneous IL-10 was undetectable in patients with HCC or controls. Only 5/22 (23%) of their patients with cirrhosis showed detectable levels of IL-10.
Another study done by Takegoshi and his colleagues.
(15) in which IFNgamma IL-12 P70, Il 12 p40 and IL-10 as well as NK cell activity were assayed in six patients with normal ALT, 22 HCV -infected individuals with chronic hepatitis (CH), 13 cases of liver cirrhosis (LC) and 26 agematched controls, no inter-group differences were observed for IL12 p70, Il 12 p40 and Il-10 production and NK cell activity.
Further studies are recommended to be done to fulfill the sources and mechanisms of increased IL-10 level in chronic hepatitis patients and the possibility to use IL-10 as a therapy to treat the active disease, also the use of IL-10 as a preliminary testing in patients with chronic hepatitis C is recommended and recommendation agrees with previous studies. 
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